A 24‐week outcome following buprenorphine maintenance among opiate users in India

References

• Ahmadi J. A randomized, clinical trial of buprenorphine maintenance treatment for Iranian patients with opioid dependency. Addictive Disorders & Their Treatment 2002; 1: 25–27
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. APA, Washington, DC 1987, 3rd rev. edn
   Google Scholar
• Auriacombe M., Franques P., Tignol J. Deaths attributable to Methadone vs. Buprenorphine in France. Journal of American association 2001; 285
   PubMed Web of Science ®Google Scholar
• Barnett P. G., Rodgers J. H., Bloch D. A. A meta‐analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 2001; 96: 683–690
   PubMed Web of Science ®Google Scholar
• Bickel W. K., Amass L., Higgins S. T., Badger G. J., Esch R. A. Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consultation and Clinical Psychology 1997; 65: 803–810
   PubMed Web of Science ®Google Scholar
• Bickel W. K., Stitzer M. L., Bigelow G. E., Liebson I. A., Jasinski D. R., Johnson R. E. Buprenorphine: dose‐related blockade of opioid challenge effects in opioid dependent humans. Journal of Pharmacology and Experimental Therapy 1988; 247: 47–53
   PubMed Web of Science ®Google Scholar
• Eder H., Rupp I., Peternell A., Fischer G. Buprenorphine in der Schwangerschaft. Psychiatrische Praxis 2001; 28: 267–269
   PubMedGoogle Scholar
• Fischer G., Gombas W., Eder H., Jagsch R., Peternell A., Stuhlinger G., Pezawas L., Aschauer H. N., Kaspar S. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 1999; 94: 1337–47
   PubMed Web of Science ®Google Scholar
• Gandhi D. H., Jaffe J. H., McNary S., Kavanagh G. J., Hayes M., Currens M. Short‐term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users. Addiction 2003; 98: 453–462
   PubMed Web of Science ®Google Scholar
• Johnson R. E., Jaffe J. H., Fudala P. J. A controlled trial of buprenorphine treatment for opioid dependence. Journal of the American Medical Association 1992; 267: 2750–2755
   PubMed Web of Science ®Google Scholar
• Lin K. M., Finder E. Neuroleptic dosage in Asians. American Journal of Psychiatry 1983; 140: 490–491
   PubMed Web of Science ®Google Scholar
• Lin K., Shen W. W. Pharmacotherapy for southeast Asian psychiatric patients. Journal of Nervous and Mental Disease 1991; 179((6))346–350
   PubMed Web of Science ®Google Scholar
• Ling W., Charuvastra C., Collins J. F. Buprenorphine maintenance treatment of opiate dependence: a multi‐centre, randomised clinical trial. Addiction 1998; 93: 475–486
   PubMed Web of Science ®Google Scholar
• Lintzeris N., Ritter A., Panjari M., Clark N., Kutin J., Bammer G. Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial. American Journal on Addictions 2004; 13: S29–S41
   PubMed Web of Science ®Google Scholar
• Mattick R. P., Ali R., White J. M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double‐blind trial with 405 opioid‐dependent patients. Addiction 2003; 98: 441–452
   PubMed Web of Science ®Google Scholar
• Mattick R. P., Kimber J., Breen C., Davoli M. Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence. 2002, Cochrane Database of Systematic Reviews, Cochrane Library Issue 4
   Google Scholar
• McLellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'Brien C. P. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association 1993; 269: 1953–1959
   PubMed Web of Science ®Google Scholar
• McLellan A. T., Luborsky L., O'Brien C. P., Woody G. E. An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous & Mental Diseases 1980; 168: 26–33
   PubMed Web of Science ®Google Scholar
• Mohan D., Dhawan A., Chopra A., Sethi H. Rapid Assessment Survey on Drug Abuse in Districts Aizawal (Mizoram), Kohima (Nagaland) and Darjeeling (West Bengal). 2001, report submitted to Ministry of Health and Family Welfare, Government of India
   Google Scholar
• Mohan D., Ray R. Community based intervention in urban slums in Delhi, India. 1997, report submitted to WHO (SEARO)
   Google Scholar
• Petitjean S., Stohler R., Deglon J. J., Livoti S., Waldvogel D., Uehlinger C., Ladewig D. Double‐blind randomized trial of buprenorphine and methadone in opiate dependence. Drug Alcohol Dependency 2001; 62: 97–104
   PubMed Web of Science ®Google Scholar
• Simoens S., Matheson C., Bond C., Inkster K., Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. British Journal of General Practice 2005; 55((511))139–146
   PubMed Web of Science ®Google Scholar
• Strain E. C., Stitzer M. L., Liebson I. A., Bigelow G. E. Buprenorphine versus methadone in the treatment of opioid dependence: self‐reports, urinalysis, and Addiction Severity Index. Journal of Clinical Psychopharmacology 1996; 16: 58–67
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime, and Ministry of Social Justice and Empowerment. Extent, Patterns and Trends of Drug Abuse in India. UNODC/MSJE, New Delhi 2004, National Survey
   Google Scholar
• West S. L., O'Neal K. K., Graham C. W. A meta‐analysis comparing the effectiveness of buprenorphine and methadone. Journal of Substance Abuse 2000; 12: 405–414
   PubMedGoogle Scholar
• Integrated Care for drug users: Principles and practice, web publication. http://www.scotland.gov.uk/Publications/2002/10/15503/11468 (accessed 25 September, 2005).
   Google Scholar